Title:
リビン由来のHLA-A24結合性癌抗原ペプチド
Document Type and Number:
Japanese Patent JP4516916
Kind Code:
B2
Abstract:
The present invention provides a partial peptide consisting of 8-11 contiguous amino acids in the amino acid sequence of livin set forth in SEQ ID NO: 1, which binds to HLA-A24 antigen and is recognized by cytotoxic T cells (CTLs), a polynucleotide encoding the peptide, and cancer vaccine comprising the peptide or the polynucleotide.
Inventors:
Noboru Sato
Toshihiko Torigoe
Hiroyuki Hario
Yoshihiko Hirohashi
Toshihiko Torigoe
Hiroyuki Hario
Yoshihiko Hirohashi
Application Number:
JP2005511574A
Publication Date:
August 04, 2010
Filing Date:
July 07, 2004
Export Citation:
Assignee:
Noboru Sato
Sumitomo Dainippon Pharma Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
International Classes:
C12N15/09; A61K35/12; A61K35/14; A61K35/74; A61K35/76; A61K38/17; A61K39/00; A61K48/00; A61P35/00; A61P37/04; C07K7/06; C07K7/08; C07K14/47; C07K14/705; C07K14/82; C07K16/28; C07K16/32; C07K19/00; C12N1/15; C12N1/19; C12N1/21; C12N5/07; C12N5/078; C12N5/09; C12N5/10; C12P21/02; C12Q1/04; G01N33/574
Domestic Patent References:
| JP2002316998A | 2002-10-31 | |||
| JP2002284797A | 2002-10-03 |
Attorney, Agent or Firm:
Yobe